Apollo, RMS launch cell therapy for orthopaedic patients
Posted on 19th June 2017 |
.jpg) |
| Apollo Hospitals has tied up with biotechnology firm Regenerative Medical Services (RMS) to launch cell therapy for bone and cartilage defects. The companies, however, did not share the financial details of the partnership. The two cell therapy products – Ossron and Chondron – will address the unmet clinical needs in the bone and cartilage treatments respectively, the companies said. As part of the pact, the treatment will be made available across all Apollo Hospitals within next six months. “Our hospitals provide the best medical outcomes at very affordable rates, that is the reason that people from around 150 countries come to India for treatment”, Apollo Hospitals Founder-Chairman Prathap C Reddy told reporters here today. Apollo’s association with Regenerative Medical Services is a step to inspire talent in India to further the advancement in developing innovative healthcare treatments to reduce the growing disease burden in the country, he added. RMS Founder and CEO Yash Sanghavi said it has taken eight years of effort and innovative research to develop the two products that will change the modalities for bone and cartilage treatment in India. Apollo Hospitals has 9,215 beds across 64 hospitals. It also has 2,500 pharmacies, over 90 primary care and diagnostic clinics and more than 110 telemedicine centres. |
|
|
|
|
Bharti Airtel defers Q2 results till Nov 14 over ambiguity on AGR verdict
Posted on 29th October 2019 |
.jpg) |
Bharti Airtel said on Tuesday it has postponed its second-quarter earnings report to mid-November, as the wireless operator sought clarity on the court ruling asking telecom firms to cough up overdue payments to the government.
Shares of the company, which was expected to release its quarterly numbers later in the day, dropped 3.3 per cent in early trade. |
|
|
Rupee slips 8 paise vs US dollar in early trade amid drop in oil prices
Posted on 7th October 2019 |
.jpg) |
The rupee on Monday opened eight paise lower at 70.96 against the US dollar amid drop in crude oil prices and rise in Asian equities. The domestic unit on Friday closed almost flat at 70.88 against after the Reserve Bank of India (RBI) in a widely expected move cut key interest rates by 0.25 percentage point. On a weekly basis, the local unit slumped by 32 paise. |
|
|
LIC pips private insurers in first-year premium growth during April-August
Posted on 13th September 2019 |
.jpg) |
In the first five months of the current financial year, first-year premiums of life insurance companies grew by 39.84% (year-on-year) at Rs 1.05 lakh crore as compared to Rs 75,588.35 crore in April-August of 2018-19. Life Insurance Corporation of India (LIC) continued to grow at a faster pace compared to private insurance players, shows the data from the Insurance Regulatory and Development Authority of India (Irdai). |
|
|
Apollo Hospitals rules out further stake sale
Posted on 13th September 2019 |
.jpg) |
Apollo Hospitals Enterprise (AHEL) has ruled out further dilution of promoters’ stake in the company. The company also said its Rs 1,337-crore stake sale of Apollo Munich Health Insurance with mortgage major HDFC will be concluded by October. Following these stake sales, the promoters’ pledged position will come down from a high of 76% to 54% by October and eventually to 20% by November or December, company sources said here. |
|
|
World trusts India on Kashmir, not us: Pakistan minister Ijaz Ahmed Shah
Posted on 13th September 2019 |
.jpg) |
In a major embarrassment for Pakistan and its Prime Minister Imran Khan, the country's Interior Minister Ijaz Ahmed Shah, a retired brigadier, said the international community didn't believe Pakistan's narrative on Kashmir; instead it is India whose version is trusted. |
|
|
|
|
| Be the first person to write a business review for Apollo, RMS launch cell therapy for orthopaedic patients |
|
|
|
